Effect of nicotine on postischemic brain inflammation.
Effect of nicotine on postischemic brain inflammation.
批准号:
7587078
负责人:
ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
金额:
$20.19万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-20 至 2010-06-30
关键词:
AdhesionsAffectAlzheimer&aposs DiseaseAnti-Inflammatory AgentsAnti-inflammatoryBlood - brain barrier anatomyBlood VesselsBrainBrain IschemiaCCL2 geneCX3C ChemokinesCX3CL1 geneCXC ChemokinesCXCL5 geneCell Adhesion MoleculesCell CommunicationCellsCentral Nervous System DiseasesCerebrovascular CirculationCerebrumChemotactic FactorsChronicConditionCoronary arteryCotinineDataDisruptionEncephalitisEndothelial CellsEndotheliumExposure toFractalkineGlucoseGoalsHumanIL8 geneITGB2 geneImmune responseIn VitroInfarctionInfiltrationInflammationInflammatoryInflammatory ResponseInjuryIntercellular adhesion molecule 1IschemiaKidneyLeadLeukocyte RollingLeukocytesLiverMediatingMediator of activation proteinMessenger RNAMiddle Cerebral Artery OcclusionMolecularMusNeurogliaNeurologicNeuronsNicotineNicotinic ReceptorsOutcomeOxygenP-SelectinPathway interactionsPeripheralPhenotypePhysiological reperfusionPlayProcessProteinsPublic HealthPurposeRateReactionRecoveryReperfusion InjuryReperfusion TherapyResearchRho-associated kinaseRisk FactorsRoleSignal PathwaySignal TransductionSmokerStimulusStrokeTestingTherapeuticThrombusTimeTraumatic Brain InjuryUmbilical veinUp-Regulationbasebeta-Chemokinescerebrovascularchemokinecigarette smokingcytokinedaydeprivationdesignenhancing factorhuman CXCL5 proteinin vitro Modelin vivoinsightmigrationmodifiable riskmonocytemortalitymouse modelneutrophilprotein expressionreceptorrelating to nervous systemresearch studyrhosizetherapeutic targettranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A substantial body of evidence suggests that nicotine adversely affects cerebral blood flow and peripheral thrombus formation by inducing breakdown of the blood-brain barrier and alterations in the cerebrovascular endothelium. Some of the alterations in brain endothelial phenotype and function are denoted as proinflammatory, indicating that nicotine may regulate expression of some proinflammatory mediators such as cytokines and adhesion molecules. Our preliminary data support this observation and indicate that chronic exposure to nicotine (14 days) has a profound effect on postischemic injury (2-fold increase in infarct size) and on the progression of the inflammatory response. Particularly, administration of nicotine markedly increased leukocyte migration into postischemic mouse brain and also induced high expression of chemokine CCL2. That chemokine is a major factor orchestrating the immune response and it plays a pivotal role in leukocyte recruitment during postichemic inflammation. To further explore this issue, we propose a research plan directed to test the hypothesis: "Nicotine augments postischemic inflammatory response in the brain by inducing a prolonged increase in expression of chemokines." Specifically, we will determine whether nicotine and/or cotonine exposure can induce or maintain the inflammatory response of brain endothelial cells through the stimulation of CCL2 expression in these cells under in vitro and in vivo basal (i.e., normal oxygen and glucose supply) and ischemia/reperfusion (I/R) conditions (specific aim 1) and to establish the components of the signaling pathway (transcription factor NF:B and Rho/Rho kinase pathway) that underlie the upregulation of CCL2 expression in mouse brain endothelial cells by nicotine during postischemic injury (specific aim 2). To accomplish our goal, we will conduct both in vitro and in vivo experiments. For in vitro experiments, brain microvessel endothelial cell cultures will be subjected to combined oxygen glucose deprivation followed by recovery (in vitro model of I/R). In vivo experiments will be performed on a mouse model of brain I/R injury (transient middle cerebral artery occlusion). Collectively, these experiments will serve to illuminate, for the first time, how nicotine can regulate postischemic inflammatory response. PUBLIC HEALTH RELEVANCE: Cigarette smoking is widely recognized as a major modifiable risk factor for stroke and it is causally associated with a worse stroke outcome. The purpose of this study is to provide a better understanding of the relationship between cigarette smoking and stroke and this may lead to the design of a rational therapeutic approach to stroke in smokers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the role of junctional adhesion molecule-A in neutrophil-driven inflammatory response in Alzheimer disease
-
批准号:10752753
-
项目类别:
-
资助金额:$65.85万
-
财政年份:2023
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
Molecular mechanism mediating apicobasal brain endothelial cells polarity in cerebral cavernous malformation type 3-lesion
-
批准号:10526456
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2022
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
The mechanism of blood brain barrier impairment in cerebral cavernous malformatio
-
批准号:8166264
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2011
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
The mechanism of blood brain barrier impairment in cerebral cavernous malformatio
-
批准号:8320860
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2011
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
The blood brain barrier in neuroinflammation
-
批准号:7781058
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2009
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
Blood-Brain Barrier in Neuroinflammation
-
批准号:8550172
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2008
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
Chemokine Effects on Blood-brain Barrier Permeability
-
批准号:6720934
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2003
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
Chemokine Effects on Blood-brain Barrier Permeability
-
批准号:6982792
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2003
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
Chemokine Effects on Blood-brain Barrier Permeability
-
批准号:6823224
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2003
-
负责人:ANUSKA V. ANDJELKOVIC-ZOCHOWSKA
-
依托单位:
海外基金